We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
Cap. Flow
-$270M
Cap. Flow %
-17.18%
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37

Top Buys

Rank Stock Value
1
BZUN
Baozun
BZUN
+$17.1M
2
MOMO
Hello Group
MOMO
+$5.31M
3
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$4.25M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.13M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.26M

Top Sells

Rank Stock Value
1
KANG
iKang Healthcare Group, Inc.
KANG
+$94.3M
2
VIPS icon
Vipshop
VIPS
+$47.3M
3
DBRG icon
DigitalBridge
DBRG
+$39.3M
4
BKD icon
Brookdale Senior Living
BKD
+$37.8M
5
CRTO icon
Criteo S.A. Ordinary Shares
CRTO
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.62%
2 Financials 6.46%
3 Consumer Discretionary 4.13%
4 Industrials 2.9%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LVS icon
126
Las Vegas Sands
LVS
$31.4B
$1.29M 0.08%
21,400
+10,500
+96% +$618K
QCOM icon
127
Qualcomm
QCOM
$164B
$1.26M 0.08%
22,300
+10,000
+81% +$540K
SPRO icon
128
Spero Therapeutics
SPRO
$68.9M
$1.25M 0.08%
103,362
-59,000
-36% -$626K
SLB icon
129
SLB Ltd
SLB
$72.7B
$1.23M 0.08%
28,200
+3,000
+12% +$130K
PRTK
130
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.23M 0.08%
227,383
– –
CCXI
131
DELISTED
ChemoCentryx, Inc.
CCXI
$1.22M 0.08%
91,776
-9,200
-9% -$105K
LITS
132
Lite Strategy Inc
LITS
$32.4M
$1.22M 0.08%
19,826
– –
LKQ icon
133
LKQ Corp
LKQ
$6.72B
$1.21M 0.08%
43,000
+5,000
+13% +$135K
CTAS icon
134
Cintas
CTAS
$86.6B
$1.2M 0.08%
24,000
+7,600
+46% +$368K
TMO icon
135
Thermo Fisher Scientific
TMO
$214B
$1.19M 0.08%
4,400
+300
+7% +$74.7K
MDCO
136
DELISTED
Medicines Co
MDCO
$1.18M 0.08%
42,500
+8,500
+25% +$200K
XOM icon
137
ExxonMobil
XOM
$650B
$1.18M 0.07%
+14,550
New +$1.11M
TBIO
138
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$1.14M 0.07%
115,488
+41,488
+56% +$318K
PLX icon
139
Protalix BioTherapeutics
PLX
$183M
$1.13M 0.07%
263,140
– –
GE icon
140
GE Aerospace
GE
$364B
$1.13M 0.07%
22,873
+337
+1% +$15.9K
MDLZ icon
141
Mondelez International
MDLZ
$82.9B
$1.12M 0.07%
22,700
+6,300
+38% +$289K
PPLI
142
People Inc
PPLI
$3.12B
$1.11M 0.07%
29,656
-1,119
-4% -$41.4K
FOCL
143
EDAP TMS S.A.
FOCL
$234M
$1.07M 0.07%
363,485
+114,342
+46% +$312K
APH icon
144
Amphenol
APH
$185B
$1.03M 0.07%
43,840
– –
SPPI
145
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1.02M 0.06%
95,246
-25,754
-21% -$276K
PM icon
146
Philip Morris
PM
$309B
$1M 0.06%
11,500
+3,500
+44% +$282K
FE icon
147
FirstEnergy
FE
$28.4B
$994K 0.06%
24,000
– –
MELI icon
148
Mercado Libre
MELI
$94.5B
$994K 0.06%
+2,000
New +$797K
APA icon
149
APA Corp
APA
$13B
$983K 0.06%
28,000
– –
LXRX icon
150
Lexicon Pharmaceuticals
LXRX
$1.03B
$952K 0.06%
181,000
+80,379
+80% +$488K
4 5
6
7 8

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q1 2019 Portfolio in Review

As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Fosun International opened a new position in Baozun worth $20.3M.

  • Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
  • Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
  • Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
  • Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
  • Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
  • Fosun International opened 45 new positions and closed 37 in Q1 2019.
  • Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.